Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT04762316
PHASE4

Composition for Treating Uterine Fibroid (SB-UF)

Sponsor: Trieu, Nguyen Thi, M.D.

View on ClinicalTrials.gov

Summary

Pregnenolone \& Pyridoxal Phosphate SB-UF for treating uterine fibroids in women's pregnancies to lose the size of fibroids and to dissolve fibroids. Uterine fibroids are a very common finding in women pregnancy of reproductive age, fibroids fast grow in the first trimester of pregnancy. SB-UF against the rapid growth of fibroids under the influence of hormones during pregnancy. Use SB-UF to think about regulating stable Oestrogen levels and dissolving fibroids. This is a substantial insight into disease pathogenesis, with a clear path toward clinical application, which would lead to a substantial advance and perfection in management or public health policy.

Official title: Uterine Fibroids Are a Prevalent Finding in Women of Reproductive Age. Ready Safety Study Extracts of Plants Pregnenolone, Pyridoxal Phosphate, and Dydrogesterone for Treating Uterine Fibroids in Women's Pregnancy.

Key Details

Gender

FEMALE

Age Range

18 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

66

Start Date

2019-01-01

Completion Date

2025-12-31

Last Updated

2026-06-08

Healthy Volunteers

No

Interventions

DRUG

SB-UF

Dosage: -Take 1tablet/2 times/day/in throughout pregnancy.

DEVICE

SB-UF Placebo

Dosage: -Take 1tablet/2 times/day/in throughout pregnancy.

Locations (1)

Saigon Biopharma Company Limited

Ho Chi Minh City, Vietnam